News & Events about Revolution Medicines Inc.
Ticker Report
6 months ago
Revolution Medicines, Inc. (NASDAQ:RVMD Get Rating) Director Thilo Schroeder purchased 100,000 shares of the firms stock in a transaction on Friday, March 10th. The stock was acquired at an average price of $20.46 per share, for a total transaction of $2,046,000.00. Following the ...
Globe Newswire
7 months ago
REWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced the pricing of its underwritten public offering of 13,636,364 shares of common stock at a ...
Market News Video
8 months ago
In trading on Thursday, shares of Revolution Medicines Inc (RVMD) touched a new 52-week high of 28.06/share. Thats a 99.29% rise, or 13.98 per share from the 52-week low of 14.08 set back on 05/12/2022...
Globe Newswire
9 months ago
Findings Published in the Journal of Medicinal Chemistry Demonstrate Compounds Exceptional Selectivity for mTORC1 over mTORC2 Tumor Regressions Observed During Combination Treatment with a Bi-Steric mTORC1-Selective Inhibitor and a KRASG12C-Selective Inhibitor in Preclinical Lung Cancer Model that ...